Open Orphan (ORPH)

Sector:

Health Care

Index:

FTSE AIM All-Share

5.88p
   
  • Change Today:
    -0.15p
  • 52 Week High: 8.00
  • 52 Week Low: 2.55
  • Currency: UK Pounds
  • Shares Issued: 533.05m
  • Volume: 1,045,207
  • Market Cap: £31.32m
  • RiskGrade: 271

Open Orphan inks three-year contract with mystery European firm

By Iain Gilbert

Date: Monday 06 Jan 2020

LONDON (ShareCast) - (Sharecast News) - Drug consulting services platform Open Orphan has won a new three-year contract with an unnamed German pharmaceutical company.
Open Orphan said the contract, which guaranteed "significant annual revenue", will see Venn Life Sciences provide Pharmacokinetic analysis with the pharmaceutical company as it builds upon its strong existing relationship with the firm.

The AIM-listed group noted that work under the contract would commence in January.

Chief executive Cathal Friel said: "This new contract is further evidence of Open Orphan delivering against one of its key objectives, transforming Venn by transitioning from ad-hoc short-term contracts to long-term contracts with high-quality customers thereby delivering secured recurring revenues for the business.

"We look forward to delivering the contract and building upon this great partnership with one of the leading companies in the European pharma industry."

As of 1055 GMT, Open Orphan shares were up 7.22% at 5.20p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Open Orphan Market Data

Currency UK Pounds
Share Price 5.88p
Change Today -0.15p
% Change -2.49 %
52 Week High 8.00
52 Week Low 2.55
Volume 1,045,207
Shares Issued 533.05m
Market Cap £31.32m
RiskGrade 271

Open Orphan Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
12.76% above the market average12.76% above the market average12.76% above the market average12.76% above the market average12.76% above the market average
2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average
Income Not Available
Growth
38.93% below the market average38.93% below the market average38.93% below the market average38.93% below the market average38.93% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average

Open Orphan Dividends

No dividends found

Trades for 25-Feb-2020

Time Volume / Share Price
16:29 156,426 @ 5.85p
16:28 4,898 @ 5.88p
15:17 84,578 @ 5.90p
14:32 50,000 @ 5.87p
14:15 100,000 @ 5.88p

Open Orphan Key Personnel

CEO Trevor Phillips
COO Tim Sharpington
CFO Leo Toole

Top of Page